Skip to content

Replimune Group REPL Total Liabilities & Equity

Total Liabilities & Equity at other companies

Amgen logo
AmgenAMGN
$92.5B+3.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$183.97M-24.2%
Immunome logo
ImmunomeIMNM
$619.79M+80.9%
CG Oncology logo
CG OncologyCGON
$1.14B+55.9%
Erasca, Inc. logo
Erasca, Inc.ERAS
$461.23M-2.1%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$919.03M+28.6%
Enterprise value$873.59M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's total liabilities & equity?
Replimune Group (REPL) reported total liabilities & equity of $333.59M in Q4 2025.
How has Replimune Group's total liabilities & equity changed year-over-year?
Replimune Group's total liabilities & equity decreased by 44.7% year-over-year, from $603.63M to $333.59M.
What is the long-term trend for Replimune Group's total liabilities & equity?
Over 4 years (2021 to 2025), Replimune Group's total liabilities & equity has grown at a 0.4% compound annual growth rate (CAGR), from $543.1M to $551.33M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.